ArticleMolecules (Basel, Switzerland)2026
Genipin as an Effective Crosslinker for High-Performance and Flexible Direct-Printed Bioelectrodes.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The development of efficient bioelectrodes requires suitable fabrication strategies, starting with the electrode material, which affects the electron transfer between the biocatalyst and the electrode surface. Then, selection and adjustment of the enzyme immobilization conditions are essential to enhance the performance of the bioelectrodes for their desirable utility. In this study, we report the fabrication of a high-performance bioelectrode using a one-step crosslinking of FAD-dependent glucose dehydrogenase (FAD-GDH) and thionine acetate as a redox mediator, with genipin serving as a natural, biocompatible crosslinker. Electrodes were manufactured on flexible polyester substrates using a direct printing technique, enabling reproducible and low-cost production. Among the tested crosslinkers, genipin significantly enhanced the catalytic performance of bioelectrodes. Comparative studies on graphite, silver, and gold electrode materials identified graphite as the most suitable due to its extended electroactive surface area. The developed bioelectrodes applied to glucose biosensing demonstrated a linear amperometric response to glucose in the range of 0.02-2 mM and 0.048-30 mM, covering clinically relevant concentrations. The application of artificial sweat confirmed high detection accuracy. These findings highlight the potential integration of genipin-based enzyme-mediator networks for future non-invasive sweat glucose monitoring platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.